Guangyan Zhangyuan
Shanghai, 200025, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
GSTK1 suppresses HCC aggravation via L-carnitine metabolism by PGAM5/DRP1 complex-mediated mitochondrial quality control.
Journal: Journal of experimental & clinical cancer research : CR
Published: July 30, 2025
RIPPLY1 suppresses cancer cell stemness via targeting TBX19 in CTNNB1 -mutated hepatocellular carcinoma.
Journal: Hepatology (Baltimore, Md.)
Published: December 08, 2024
Comprehensive single-cell analysis reveals mast cells' roles in cancer immunity.
Journal: Oncogene
Published: October 15, 2024
Erratum: PTPROt aggravates inflammation by enhancing NF-κB activation in liver macrophages during nonalcoholic steatohepatitis: Erratum.
Journal: Theranostics
Published: June 06, 2022
Is β-catenin mutation in murine hepatocytes sufficient to induce liver tumorigenesis?
Journal: Journal of hepatology
Published: March 28, 2022
The zinc finger protein Miz1 suppresses liver tumorigenesis by restricting hepatocyte-driven macrophage activation and inflammation.
Journal: Immunity
Published: February 27, 2020
lncRNA PCBP1-AS1 Aggravates the Progression of Hepatocellular Carcinoma via Regulating PCBP1/PRL-3/AKT Pathway.
Journal: Cancer management and research
Published: February 13, 2020
Correction: VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR-PI3K-AKT pathway.
Journal: Oncogene
Published: November 09, 2019
Effect of lymph nodes count in node-positive gastric cancer.
Journal: Journal of Cancer
Published: October 26, 2018
Last Updated: 09/26/2026